Large-scaled analysis identifies biomarkers in glaucoma, suggesting new therapeutic opportunities.
Our findings provide new insights into the proteomic basis of glaucoma and highlight promising opportunities for developing targeted therapies.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: